摘要
目的探讨新形势下民营医药企业如何实施并购战略。方法从并购战略的内涵、类型、民营医药企业实施并购战略的动因出发,分析民营医药企业如何选择并购战略模式以及如何处理并购后的问题。结果与结论民营医药企业可以实施能提高企业竞争力的横向并购和能降低交易费用、稳定经营环境的纵向并购,以通过外部并购实现企业快速扩张。并购后还应注重并购双方企业间战略整合、管理整合和文化整合等问题,以更好的实现并购目标。
Objective To investigate how to implement the mergers and acquisitions strategy of the private pharmaceutical companies under the new situation.Methods From the content,type and motivation of mergers and acquisitions strategy implemented by private pharmaceutical companies,analyze the private pharmaceutical companies to choose how to deal with mergers and acquisitions strategy mode and after the merger issue.Results and Conclusion The private pharmaceutical companies can implement horizontal mergers to improve the competitiveness of enterprises and vertical mergers to reduce transaction costs and stabilize business environment,so that the companies can achieve rapid expansion through outside mergers.Mergers and acquisitions should also focus on strategic conformity,management conformity and cultural conformity between merger enterprises,in order to achieve better merger target.
出处
《中国药事》
CAS
2010年第12期1165-1167,1171,共4页
Chinese Pharmaceutical Affairs
关键词
民营医药企业
横向并购
纵向并购
并购后整合
private pharmaceutical companies
horizontal mergers
vertical mergers
acquisitions post merger conformity